Contractor
XLCARE PHARMACEUTICALS INC
- UEI
- MEAUS5WHBJJ7
- Parent UEI
- K7TKCHBK8K72
- Resolved by
- uei
- Confidence
- 1.000
Active from Mar 4, 2026 to Jul 30, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79726D0120 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | May 6, 2026 | — |
| 36E79722D0023 THIS MODIFICATION IS ISSUED TO EXERCISE THE 4TH OPTION YEAR FOR PANTOPRAZOLE TABLETS UNDER CONTRACT 36E79722D0023. | Department of Veterans Affairs | — | May 18, 2026 | — |
| 36F79721D0091 TPR | Department of Veterans Affairs | — | Mar 4, 2026 | — |
| 36E79723D0018 EXERCISE OPTION YEAR 3 LACOSAMIDE 10MG/ML INJ,SOLN (PACK) WITH NO PRICE CHANGES. | Department of Veterans Affairs | — | Apr 10, 2026 | — |
| 36E79726D0027 NEW AWARD FOR CARBIDOPA/LEVODOPA IMMEDIATE-RELEASE (IR) TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS JUNE 21, 2026 TO JUNE 20, 2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Mar 27, 2026 | — |
| 36E79726D0024 NEW AWARD FOR ALLOPURINOL TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS MAY 30, 2026 TO MAY 29, 2027 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Mar 9, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier MEAUS5WHBJJ7, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.